Answers are grounded in this paper and cite their sources.
The development of bio-analysis of drug molecules over the last 10 years is reviewed, focusing on advances in sample preparation, liquid chromatography and detection. 2. Developments have led to improvements in detection sensitivity, enhancements in specificity and increased capacity. 3. Emerging technologies such as monolithic column chromatography and miniaturized chip-based systems are discussed.
No takes yet. Share an insight, caveat, or question.
Plumb et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: